Vol. 10 No. 2 (2018)

Artigos

• Treatment patterns, resource use and cost-of-illness of advanced non-small lung cancer in Brazilian private institutions

  Clarissa Baldotto, Guilherme Julian, Eldsamira Mascarenhas, Mariana Laloni, Carla Azevedo, Diego Kashiura, Eloisa Moreira, Ana Paula Oliveira

  86-106

  • PDF (Português (Brasil))

• Cost-effectiveness and budgetary impact of lipegfilgrastim for the reduction of chemotherapy-induced neutropenia in Brazil

  Agota Szende, Jennifer Urwongse, Erika Szabo, Jean Klastersky, Udo Mueller, Stephen Stefani, Boxiong Tang

  107-117

  • PDF

• Hodgkin’s lymphoma unmet medical needs in Brazil: experts’ perspective

  Valeria Buccheri, Guilherme Perini, Adriana Penna, Talita Silveira, Ricardo Bigni, Flavia Pimenta, Juliano Cerci, Carlos Eduardo Bacchi, Renato Oliveira, Tania Barreto

  118-125

  • PDF

• Cost-effectiveness analysis of abiraterone for metastatic, castrate-resistant prostate cancer following previous chemotherap

  Lisiane Leal, Rafael José Alves, Carisi Anne Polanczyk, Rodrigo Ribeiro

  126-133

  • PDF (Português (Brasil))

• Clinical and economic evaluation of dexmetomidine use at an university hospital

  Íkaro Matheus Lima, Iara Antônia Nogueira

  134-139

  • PDF (Português (Brasil))

• Regulation of innovative drugs in Portugal as an example of transparency, accountability and public governance: not all areas are born equal

  Pedro Miguel Correia, Maria João Vergueiro

  140-147

  • PDF (Português (Brasil))

• Cost-effectiveness analysis of daratumumab, bortezomib, and dexamethasone combination in comparison to carfilzomib, elotuzumab and ixazomib-based therapies for the treatment of patients with relapsed and refractory multiple myeloma from a Brazilian pr

  Cyntia Fioratti, Ricardo Rosim, Luciana Scaccabarozzi, Glaciano Ribeiro

  148-156

  • PDF (Português (Brasil))

• Prostate cancer with bone metastasis: budget impact to the Brazilian Private Heathcare System

  Enzo Asano, Hellen Kim, Mariana Aguila, Sandra Navarro, Roberta Fernandes

  157-164

  • PDF (Português (Brasil))

• Unmet needs in multiple myeloma in Brazil from physicians’ perspective – barriers in quality of life and disease management

  Angelo Maiolino, Jorge Pinto Neto, Leonardo Leite, Fernanda Seguro, Walter Braga, Karla Zanella, Jairo Jose Sobrinho, Renato Oliveira, Guilherme Julian, Paula Tanaka

  165-171

  • PDF

• Treatment patterns of Hodgkin’s lymphoma in Brazil: experts’ perspective

  Talita Silveira, Valeria Buccheri, Guilherme Perini, Ricardo Bigni, Adriana Penna, Flavia Cristina Pimenta, Juliano Julio Cerci, Carlos Eduardo Bacchi, Renato Oliveira, Tania Barreto

  172-178

  • PDF

• Cost of the medication error and adverse drug events in the medication therapy chain: review literature as a topic

  Renata Vilela, Daniele Pompeo, Marli Jericó, Alexandre Werneck

  179-189

  • PDF (Português (Brasil))

• New treatment approaches for relapsing/refractory Hodgkin’s lymphoma: An overview of the Brazilian scenario

  Guilherme Perini, Valeria Buccheri, Talita Silveira, Adriana Penna, Juliano Julio Cerci, Carlos Eduardo Bacchi, Luciana Fanti, Tânia Barreto

  190-197

  • PDF

• The remuneration model defining care: why is inefficiency in elderly care rewarded?

  Martha Regina Oliveira, Renato Veras, Hésio Cordeiro

  198-202

  • PDF (Português (Brasil))

• Influence of governance structure on organizational competency development: health services study

  Djair Picchiai, Roseli Soligo

  203-212

  • PDF (Português (Brasil))